收藏切换
Analysis of the therapeutic efficacy of Mahuang Danggui powder in acute exacerbation of cold-type bronchial asthma
收藏切换
Xueqin WANG, Zhengding DENG, Gang XUE
World Clinical Drug | 2026, 47(7) : 726 - 731
Less
收藏切换
World Clinical Drug | 2026, 47(7): 726-731
• Article •
Analysis of the therapeutic efficacy of Mahuang Danggui powder in acute exacerbation of cold-type bronchial asthma
Full
Xueqin WANG, Zhengding DENG, Gang XUE
Affiliations
  • Department of Internal Medicine, Rugao Hospital of Traditional Chinese Medicine, Nantong 226500, Jiangsu Province, China
Published: 2026-07-10 doi: 10.13683/j.wph.2026.07.004
Outline
收藏切换
Objective

To observe the efficacy of Mahuang Danggui powder in treating acute exacerbation of cold-type bronchial asthma.

Methods

A total of 120 patients with acute exacerbation of cold-type bronchial asthma were randomly divided into the treatment group and the control group, with 60 cases in each group. Both groups received nebulized inhalation therapy with budesonide suspension for inhalation. The treatment group additionally received Mahuang Danggui powder. The acute exacerbation clinical feature scores, forced expiratory volume in one second as a percentage of predicted value(FEV1%pred), peak expiratory flow(PEF), eosinophil(EOS) count, levels of total immunoglobulin E(IgE), interleukin(IL)-4, and IL-5 were compared between the two groups before and after treatment.

Results

After treatment, the clinical feature scores decreased in both groups, and the scores in the treatment group were significantly lower than those in the control group(P<0.05). After treatment, FEV1%pred and PEF in both groups increased compared with those before treatment, and the values in the treatment group were higher than those in the control group(P<0.05). After treatment, the levels of EOS, total IgE, IL-4, and IL-5 in both groups decreased compared with those before treatment, and the levels in the treatment group were lower than those in the control group(P<0.05). No significant adverse reactions were observed in either group.

Conclusion

Mahuang Danggui powder is effective in the treatment of acute exacerbation of cold-type bronchial asthma.

Mahuang Danggui powder  /  cold-type asthma syndrome  /  bronchial asthma  /  pulmonary function
王雪芹, 邓正定, 薛刚. 麻黄当归散在冷哮型支气管哮喘急性发作期的疗效探析. 世界临床药物, 2026 , 47 (7) : 726 -731 . DOI: 10.13683/j.wph.2026.07.004
Xueqin WANG, Zhengding DENG, Gang XUE. Analysis of the therapeutic efficacy of Mahuang Danggui powder in acute exacerbation of cold-type bronchial asthma[J]. World Clinical Drug, 2026 , 47 (7) : 726 -731 . DOI: 10.13683/j.wph.2026.07.004
Year 2026 volume 47 Issue 7
52
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2026.07.004
  • Receive Date:2025-11-02
  • Online Date:2026-11-05
  • Published:2026-07-10
Article Data
Affiliations
History
  • Received:2025-11-02
Funding
Affiliations
    Department of Internal Medicine, Rugao Hospital of Traditional Chinese Medicine, Nantong 226500, Jiangsu Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.07.004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT